Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Patient-Controlled Epidural Bupivacaine-Fentanyl Offer Advantages Over Continuous Epidural Infusion After Uterine Arteries Embolization? A Controlled Prospective Study

NCT02236585 is registered in ClinicalTrials.gov with Imam Abdulrahman Bin Faisal University as lead sponsor.

NCT NCT02236585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02236585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Patient-Controlled Epidural Bupivacaine-Fentanyl Offer Advantages Over Continuous Epidural Infusion After Uterine Arteries Embolization? A Controlled Prospective Study
Lead sponsor
Imam Abdulrahman Bin Faisal University
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2015
Completion date
June 30, 2019
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

uterine artery embolization for uterine leiomyomata